Searchable abstracts of presentations at key conferences in endocrinology

ea0056p33 | Adrenal cortex (to include Cushing's) | ECE2018

ACTH stimulation test for study of primary aldosteronism

Cunha Nelson , Gomes Leonor , Paiva Isabel , Oliveira Diana , Lages Adriana , Ventura Mara , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Primary aldosteronism (PA) is the principal cause of arterial hypertension potentially treatable. The diagnosis is dependent of tests to identify patients who will benefit most with surgical treatment. ACTH stimulation test (AST) has been described as a useful confirmatory test, potentially identifying bilateral disease in patients without adrenal tumors.Aim: Evaluate the AST in patients with hypertension and positive screening test for PA,...

ea0056p104 | Clinical case reports - Pituitary/Adrenal | ECE2018

A new gene – TMEM127 – in familial pheochromocytoma/paraganglioma syndromes

Ventura Mara , Paiva Isabel , Melo Miguel , Lages Adriana , Oliveira Diana , Martins Diana , Cunha Nelson , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Pheochromocytomas are catecholamine-producing tumors originated from the chromaffin cells of the adrenal medulla. Although usually sporadic, this tumors could be associated with germline mutations in about 40% of cases. TMEM127 has recently been identified as a novel gene conferring increased susceptibility to pheochromocytoma.Case report: A 42-year-old woman was referred to our Hospital to perform a right adrenalectomy for pheochromocytoma...

ea0056p322 | Clinical case reports - Thyroid/Others | ECE2018

Performance-enhancing drugs and adverse endocrine effects

Oliveira Diana , Lages Adriana , Paiva Isabel , Ventura Mara , Cunha Nelson , Fadiga Lucia , Catarino Diana , Paiva Sandra , Carrilho Francisco

Introduction: Performance-enhancing drug (PED) use is currently a common practice both inside and outside the sports competition scenario, and its adverse health effects remain underappreciated.Case report: We report the case of a 26-year-old man, bodybuilding practitioner, no relevant medical history, family history of autoimmune disorders. Referred to the emergency room with polydipsia, polyuria, blurred vision associated with a post-prandial capillary...

ea0056p510 | Diabetes therapy | ECE2018

Psychopathological determinants of enhanced quality of life in continuous subcutaneous insulin infusion therapy

Pereira Miguel , Goncalves Ana , Neves Celestino , Oliveira Sofia , Esteves Cesar , Arteiro Cristina , Costa Anabela , Redondo Carmo , Carvalho Davide

Introduction: Scientific progress allowed an evolution on the therapeutic of diabetes mellitus. Continuous subcutaneous insulin infusion therapy (CSII) is one good example, but, beside patients motivation little is known about other psychological factors of success in this therapeutic and how they contribute to quality of life (QoL).Objectives: Determining some psychopathological predictors of CSII satisfaction and QoL improvement in patients on CSII the...

ea0056p775 | Paediatric endocrinology | ECE2018

Final height in cancer survivors undergoing treatment with somatotropin

Pereira Catarina de Oliveira , Caetano Joana Serra , Carvalho Alice , Brito Manuel , Cardoso Rita , Dinis Isabel , Mirante Alice

Somatotropin is essential not only for linear growth but also for important metabolic functions. Its deficiency is usually the first and most common endocrinopathy induced by cancer disease and its treatments, mainly cranial irradiation. Although somatotropin replacement therapy is safe and effective in promoting a better linear growth, studies of final height in childhood cancer survivors treated with somatotropin are limited. This study was performed to examine growth outcom...

ea0056ep68 | Diabetes, Obesity and Metabolism | ECE2018

Diabetic ketoacidosis and dapagliflozin: a case report

Catarino Diana , Ribeiro Cristina , Oliveira Diana , Martins Diana , Lages Adriana , Ventura Mara , Cunha Nelson , Fadiga Lucia , Marques Bernardo , Carrilho Francisco

Introduction: Dapagliflozin is an oral antidiabetic drug, recently approved for type 2 diabetes and is a sodium-glucose cotransporter type 2 inhibitor (iSGLT2). Its mechanism of action is glycosuria induction, associated with lowering glycemia. The effects of SGLT2 inhibition are insulin-independent, and efficacy is not affected by declining β-cell function or insulin resistance. Additional benefits: weight loss, reduction in blood pressure, lower inciden...

ea0073aep742 | Thyroid | ECE2021

Anomalous uptake of 131-iodine in an endometriosis cyst

Rita Elvas Ana , Marques Bernardo , Couto Joana , Raquel G. Martins , Santos Jacinta , Martins Teresa , Oliveira Sofia , Rodrigues Fernando

IntroductionRadioiodine whole-body scintigraphy plays an important role in the follow-up of patients with differentiated thyroid carcinoma (DTC), as it is highly accurate in detecting thyroid residues and recurrent disease. Unusual 131-iodine uptake outside the thyroid bed and areas of physiological uptake is strongly suggestive of distant metastasis. However, uncommon uptake may occur and lead to diagnostic errors.Case report<...

ea0073ep209 | Thyroid | ECE2021

Differentiated thyroid carcinoma with metastatic presentation

Almeida Lucia , Almeida Ferreira Marta , Sousa Ana , Alves Helena , Ramalho Diogo , Correia Sara , Maria João Oliveira

IntroductionFollicular thyroid carcinoma (FTC) has metastasis in 10-15%; papillary thyroid carcinoma (PTC) rarely metastasizes. Bone metastasis are rare and can cause pain, fractures and spinal cord compression.Case-172 year-old male referred to the hospital with lower back pain. Imaging examination revealed lytic lumbar lesions. Thoracic-abdominal-pelvic-CT showed trachea compression by a multinodular right ...

ea0092ps3-25-04 | Case Reports 2 | ETA2023

Dupilumab-related graves disease: A case report

Gama Catarina , Oliveira Margarida , Antunes Carolina , Calvo Paula , Lopes Leonor , Cunha Clara , Marques Bernardo , Branco Pedro , Sequeira Duarte Joao

Introduction: Graves Disease (GD) is an autoimmune disease, in which CD4+ Th2 cells secrete interleucin-4 (IL-4) and IL-5 and activate antibody production. IL-4 has been considered a therapeutic target for treatment of immune-related diseases, by enhancing and redirecting T and B cell function. Dupilumab, a monoclonal antibody, inhibits IL-4 and IL-13 and is currently used for treatment of atopic dermatitis, nasal polyposis and asthma. There is a single case report of painless...

ea0093oc11 | Oral communication 2: Neuroendocrinology | EYES2023

Soluble alpha klotho, a new biomarker of growth hormone action

Schweizer Junia Ribeiro de Oliveira Longo , Schilbach Katharina , Gagliardo Anica Pauline , Haenelt Michael , Peters Annette , Thorand Barbara , Bidlingmaier Martin

Background: Soluble alpha klotho (sαKL) is high in active acromegaly, normalizes after disease control, and therefore is suggested as a new biomarker for growth hormone (GH) excess. However, little is known about the impact of biological variables other than GH.Methods: Serum sαKL (pg/ml) was measured by ELISA (IBL, Hamburg, Germany). We first evaluated pre-analytical stability, defined a reference interval for sαKL in healthy subjects (A:...